First Page | Meta Content | |
---|---|---|
Document Date: 2007-07-27 10:04:27Open Document File Size: 309,50 KBShare Result on FacebookCityBruxelles / /CompanyBentham Science Publishers Ltd. / Sanofi / /CountryGuinea / Belgium / United States / /CurrencyUSD / / /EventProduct Issues / Product Recall / FDA Phase / / /IndustryTermhuman radioimaging applications / level food intake / direct interaction site / pharmaceutical / potential therapeutic applications / prevention of obesity / imaging / chemical structures / food / food consumption / food intake suppression / food intake / brain microdialysis device / food tasteperception / Chemical structure / sweet food intake / therapeutic applications / treatment of obesity / /MedicalConditionhyperinsulinemia decrease / allergies / hyperinsulinemia / schizoaffective disorders / neuroinflammatory diseases / nausea / obesity / bradycardia / memory diseases / agonist-induced hypotension / insulin resistance / schizophrenia / hyperglycemia / hypothermia / chronic administration / pain / patient’s schizophrenia / diseases / dizziness / Depression / /MedicalTreatmentinduced hypothermia / /OrganizationEcole de Pharmacie / SR141716A administration / FDA / p.o. administration / /PersonRoger Pertwee / Lambert Another / Muccioli / John Huffman / / /PositionDean / author / representative / /Productnaloxone / SR141716A / nicotine / This / /RadioStationAM-251 / /TechnologyLAN / molecular modeling / X-ray / Tomography / cloning / /SocialTag |